Safety Information for Your Research
You want to make sure that your dog's medicine for treating osteoarthritis pain is safe. Check out Galliprant's important safety information.
Canine osteoarthritis can take away from moments that matter. Galliprant is a first-of-its-kind NSAID that targets the source of canine osteoarthritis pain and inflammation while reducing the impact on kidney and liver health.ǂ
Strengths Available:
20mg
60mg
100mg
Package Count:
30
Tablets
90
Tablets
ǂ Monitoring is recommended if used long-term.
* Approved for use in dogs older than 9 months of age and greater than 8 pounds.
ǂ Monitoring is recommended if used long-term.
* Approved for use in dogs older than 9 months of age and greater than 8 pounds.
Early signs of canine osteoarthritis pain can be hard to recognize and 50% of dogs with the disease aren't diagnosed until later in life.1 As soon as you notice signs of discomfort, talk to your veterinarian about Galliprant.
Targeted action
From first diagnosis*
Safe to use daily
Don't let canine osteoarthritis steal the joy. Learn about why Galliprant is a great choice to help treat your dog's osteoarthritis pain and inflammation – and help protect the moments that matter.
* Approved for use in dogs older than 9 months of age and greater than 8 pounds.
Take the Galliprant dose prescribed by your veterinarian out of the bottle and call your dog.
Give your dog the flavored, chewable Galliprant tablet.
You're all set for the day! Go back to sharing special moments.
You want to make sure that your dog's medicine for treating osteoarthritis pain is safe. Check out Galliprant's important safety information.
When it comes to osteoarthritis pain relief, your veterinarian knows best. Talk to them to see if Galliprant is right for your dog.
Galliprant is an NSAID that controls pain and inflammation associated with osteoarthritis in dogs.
Not for use in humans. Keep out of reach of children and pets. Monitoring is recommended if used long term. Should not be used in dogs who are allergic to grapiprant or with other anti-inflammatory drugs. The safe use of Galliprant has not been studied in dogs younger than 9 months of age and less than 8 pounds, breeding, pregnant or lactating dogs, or dogs with heart disease. The most common adverse reactions were vomiting, diarrhea, decreased appetite and tiredness.
View full product label for complete safety information or contact your veterinarian.
© 2020 Elanco or its affiliates.
Galliprant, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates.
PM-US-19-0323(4)